Cerebras stock hits post-IPO low, tumbling 20% for the week on Nvidia pressure and lockup expiration25m ago State of the Field: AI for Epistemics and Coordination42m ago The Netherlands considers banning Meta AI glasses as some retailers pull them from shelves47m ago AI can’t fix a business system with broken processes49m ago How to apply to AI safety fellowships (and beyond)1h ago Anthropic funds $100M academy to train deployed AI engineers1h ago Decagon Joins OpenAI’s B2B Marketplace as a Launch Partner1h ago Humanoid Robots Are Leaving Safety Cages. Proving Actual Safety Is Harder1h ago Apple to Tighten Mac Data Controls in Guard Against AI Agents2h ago Meta open sources code to let you make Muse AI gadgets2h ago Sean Parker is rebuilding Stability AI around music2h ago CrowdStrike and CoreWeave bring AI security to machine speed2h ago Dialogue with Eliezer Yudkowsky on Neural Networks2h ago Amazon’s New Push to Get Buy-In for Data Center Build-Out3h ago

Cerebras stock hits post-IPO low, tumbling 20% for the week on Nvidia pressure and lockup expiration25m ago State of the Field: AI for Epistemics and Coordination42m ago The Netherlands considers banning Meta AI glasses as some retailers pull them from shelves47m ago AI can’t fix a business system with broken processes49m ago How to apply to AI safety fellowships (and beyond)1h ago Anthropic funds $100M academy to train deployed AI engineers1h ago Decagon Joins OpenAI’s B2B Marketplace as a Launch Partner1h ago Humanoid Robots Are Leaving Safety Cages. Proving Actual Safety Is Harder1h ago Apple to Tighten Mac Data Controls in Guard Against AI Agents2h ago Meta open sources code to let you make Muse AI gadgets2h ago Sean Parker is rebuilding Stability AI around music2h ago CrowdStrike and CoreWeave bring AI security to machine speed2h ago Dialogue with Eliezer Yudkowsky on Neural Networks2h ago Amazon’s New Push to Get Buy-In for Data Center Build-Out3h ago

Healthcare Industry & Manufacturing

How Biotech And Pharma Adopt AI And The Supply Chain Opportunities

ForbesPublished 5 hours ago

Read the full article

Biotech and pharmaceutical companies are rapidly integrating AI technologies primarily in research and development and precision medicine. This adoption is creating new challenges and opportunities, particularly within their supply chains.

More in Healthcare

Healthcare6 min read

How AI Assistants Get Paid Will Decide Whether They Help Or Harm Patients

Forbes10h ago

Healthcare5 min read

The AI Chatbots That Tech Companies Are Aggressively Pushing to Billions of Users Appear to Be Causing Serious Psychological Harms, New Research Finds

Futurism10h ago

The Quest to Quiet Hospital Alarms

The Wall Street Journal7h ago